LMP Faculty Promotion 2016

Monday, June 06, 2016

We are pleased to congratulate the eight faculty members in LMP who received Provostial approval for promotion effective July 1, 2016.  These highly respected individuals are being recognized by their local, national and international peers for their excellent accomplishments in scholarship, teaching and academic patient care.
 

 

Faculty promoted to the rank of Professor

 

 

 

 

 

Isabelle Aubert, Sunnybrook Research Institute, is internationally distinguished for her innovative research program that focuses on developing therapies to halt neurodegeneration and promote brain regeneration, particularly in cases related to Alzheimer’s Disease (AD).  Since 2010, Dr. Aubert has concentrated on developing novel treatment strategies for AD.  She uses animal models to test an innovative approach for delivery of therapeutics based on transient disruption of the blood-brain barrier (BBB) using MRI-guided focused ultrasound (MRIgFUS).  Dr. Aubert’s previous research on cholinergic neurotransmission has yielded several key papers.   She has also been cited as an excellent graduate student supervisor.

 

 

 

 

 

Natasha Crowcroft, Public Health Ontario, is recognized by the international community as a leading expert in the field of infectious disease control, particularly in the area of immunization.   She has made substantial contributions in the following areas: the burden of pertussis, measuring the burden of infectious disease in Ontario, causes of encephalitis, research on influenza outbreaks, sero-epidemiology and vaccinology.   Her excellent creative professional activity created effective infrastructure for infectious disease control in Public Health Ontario.  Dr. Crowcroft’s research and professional activity have a profound impact on public health policy and practice both in Canada and on the international stage.
 

 

 

 

 

Janice Robertson, Tanz Centre for Research in Neurodegenerative Diseases, is internationally recognized for her excellent and innovative research on the pathogenic mechanisms of Amyotrophic Lateral Sclerosis (ALS).   She identified a pathologically misfolded form of SOD1 as a therapeutic target for ALS and is currently running a preclinical immunotherapy trial in canine degenerative myelopathy (caused by mutations in SOD1).  In addition, she has recently generated TDP-43 and C9orf72 transgenic mouse models and is part of a consortium of neurodegeneration researchers at the University of Toronto developing zebrafish models for drug screening.  Dr. Robertson has also excelled in undergraduate and graduate student supervision.

 

 

Faculty promoted to the rank of Associate Professor

 

 

 

 

Martin Chang, Mount Sinai Hospital is a nationally recognized expert in breast cancer pathology, particularly in HER2 testing.   He has developed an independent and innovative translational research program on breast cancer pathology and genomics.  His innovative approaches identified pathologic predictors of recurrence and of treatment response in host factors in breast cancer progression and in molecular correlates of structural/histologic changes.  He has changed standards of practice through the development of guidelines.  In addition, Dr. Chang has an exemplary professional practice characterized by diagnostic consultations, invited talks, and important publications.
 

Blaise Clarke, University Health Network  is a nationally recognized expert in hereditary gynecologic cancers, specifically cancers associated with Lynch syndrome.  He has developed a research program focusing on the application of molecular findings from high throughput technologies of well annotated tissue cohorts to derive clinically useful biomarkers to improve patient care.   His creative professional activities center around test innovation and implementation into the clinical diagnostic laboratory.   Dr. Clarke’s excellent research has resulted in changes in clinical practice and patient management.
 

 

 

 

 

Jason Fish, Toronto General Research Institute, is a vascular biologist, who has had major impact on the field of vascular inflammation.  Since establishing his independent research program in vascular development, Dr. Fish has focused on the role of miRNA and long non-coding RNAs in the control of vascular inflammation and atherosclerosic disease.  He has made discoveries in the identification of miRNA transfer from endothelial cells to monocytes, which modulates the release of inflammatory mediators by these cells.  His excellent discovery elucidates new mechanisms of vascular disease that may lead to new diagnostic and therapeutic approaches.  Dr. Fish is cited as an excellent graduate student supervisor.
 

 

 

 

 

 

Richard Kirsch, Mount Sinai Hospital, is recognized for his excellent academic contributions to gastrointestinal pathology, especially in research on carcinoma of the colon and hepatic fibrosis.    He has contributed to improving the diagnosis and treatment of colorectal cancer (CRC) through his translational research and his leadership in quality initiatives at provincial, national and international levels.  He has led initiatives that have improved the detection of venous invasion (IV) in CRC, an important prognostic factor that predicts metastatic disease.   His work has changed practice leading to the wider awareness of key morphologic clues and use of elastin stains in the assessment of VI in CRC.  He also provides expert academic consultations to support pathologists across Canada.

 

Tracy Stockley, University Health Network, is well-recognized nationally for her creative professional activities in innovative molecular diagnostic tests.  Her research interests are in the genetic basis of deafness and hearing loss, and the development and implementation of novel diagnostic methods and technologies in heritable disease and acquired cancers.   Dr. Stockley has established new paradigms in molecular diagnostics to ensure clinically useful genetic tests for patient care.   Her publications have enabled other clinical laboratories to uptake new molecular assays to detect genetic mechanisms of disease.  Her expertise is sought by international, national and provincial committees, which has led to contributions to new practice guidelines and to education.